ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Efficacy and cost-effectiveness of Stem Cell injections for symptomatic relief and strUctural improvement in people with Tibiofemoral knee OsteoaRthritis: protocol for a randomised placebo-controlled trial (the SCUlpTOR trial)

Liu, Xiaoqian; Robbins, Sarah; Wang, Xia; Virk, Sonika; Schuck, Karen; Deveza, Leticia A.; Oo, Win Min; Carmichael, Kirsty; Antony, Benny; Eckstein, Felix; Wirth, Wolfgang; Little, Christopher; Linklater, James; Harris, Anthony; Humphries, David; O'Connell, R.; Heller, Gillian; Buttel, Thomas; Lohmander, Stefan; Ding, Changhai; Hunter, David J.*南方医科大学; 河北医科大学
BMJ Open2021-11DOI: 10.1136/bmjopen-2021-056382
9被引14阅读
引用收藏
分享

摘要

Introduction Knee osteoarthritis (KOA) is a highly prevalent disabling joint disease. Intra-articular stem cell therapy is increasingly being used for treating KOA with little high-quality evidence to support its use. The aim of this study is to investigate the efficacy, safety and cost-effectiveness of allogeneic mesenchymal stem cells (Cymerus MSCs) for treating symptomatic tibiofemoral KOA and improving knee structure over 24 months. Methods and analysis The Stem Cell injections for symptomatic relief and strUctural improvement in people with Tibiofemoral knee OsteoaRthritis study is a phase III, multi-centre, parallel, superiority, randomised, double-blind, placebo-controlled trial, which will be conducted in Sydney and Hobart, Australia. 440 participants (220 per arm) aged over 40 years with painful KOA and mild to moderate structural change on X-ray (Kellgren and Lawrence grade 2 or 3) with medial minimum joint space width between 1 and 4 mm in the study knee will be recruited from the community and randomly allocated to receive either intra-articular MSCs or saline at baseline, week 3 and week 52. The coprimary outcomes will be the proportion of participants achieving patient-acceptable symptom state for knee pain at 24 months and quantitative central medial femorotibial compartment cartilage thickness change from baseline to 24 months. Main secondary outcomes include change in knee pain, Patient Global Assessment, physical function, quality of life and other structural changes. Additional data for cost-effectiveness analysis will also be recorded. Adverse events will be monitored throughout the study. The primary analysis will be conducted using modified intention-to-treat. Ethics and dissemination This protocol has been approved by The University of Sydney (USYD) Human Research Ethics Committee (HREC) #: 2020/119 and The University of Tasmania (UTAS) HREC #: H0021868. All participants will be required to provide informed consent. Dissemination will occur through conferences, social media, and scientific publications.

学科与关键词

关键词
rheumatologyclinical trialsknee
相关
加载中…
  • Intra-Articular Mesenchymal Stromal Cell Injections Are No Different From Placebo in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Dai, Wenli; Leng, Xi; Wang, Jian; Shi, Zhanjun; Cheng, Jin; Hu, Xiaoqing*; Ao, Yingfang*Arthroscopy - Journal of Arthroscopic and Related Surgery, 2021, 37(1): 340-358.被引 26
  • What is the optimal dose of adipose-derived mesenchymal stem cells treatment for knee osteoarthritis? A conventional and network meta-analysis of randomized controlled trials
    Huang, Zongyuan*; Zhang, Shuai; Cao, Mingde; Lin, Zhujian; Kong, Ling; Wu, Xin; Guo, Qianshi; Ouyang, Yuxiang; Song, Yancheng*Stem Cell Research & Therapy, 2023, 14(1): 245.被引 1
  • Combination of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) in the treatment of knee osteoarthritis: a meta-analysis of randomised controlled trials
    Zhao, Jinlong; Liang, Guihong; Han, Yanhong; Yang, Weiyi; Xu, Nanjun; Luo, Minghui; Pan, Jianke; Liu, Jun*; Zeng, Ling-Feng*BMJ Open, 2022, 12(11): e061008.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
BMJ Open
发表日期
2021-11
卷期
第 11 卷, 第 11 期
页码
e056382
DOI
10.1136/bmjopen-2021-056382
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
NHMRC Programme Grant [APP1162874]

作者

  • L

    Liu, Xiaoqian (第一作者)

    inst med

  • R

    Robbins, Sarah

    inst med

查看全部 21 位作者收起作者
  • W

    Wang, Xia

    inst med

  • V

    Virk, Sonika

    inst med

  • S

    Schuck, Karen

    inst med

  • D

    Deveza, Leticia A.

    inst med

  • O

    Oo, Win Min

    inst med

  • C

    Carmichael, Kirsty

    inst med

  • A

    Antony, Benny

    inst med

  • E

    Eckstein, Felix

  • W

    Wirth, Wolfgang

  • L

    Little, Christopher

    inst med

  • L

    Linklater, James

  • H

    Harris, Anthony

  • H

    Humphries, David

  • O

    O'Connell, R.

  • H

    Heller, Gillian

  • B

    Buttel, Thomas

  • L

    Lohmander, Stefan

  • D

    Ding, Changhai

    inst med · southern med univ

  • H

    Hunter, David J. (通讯)

    inst med · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417